Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.57 |
| ▸ | POLB | P06746 | 1/20 | 0.57 |
| ▸ | ERCC1 | P07992 | 1/20 | 0.57 |
| ▸ | MAPT | P10636 | 1/20 | 0.57 |
| ▸ | TSHR | P16473 | 1/20 | 0.57 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.57 |
| ▸ | FEN1 | P39748 | 1/20 | 0.57 |
| ▸ | ERCC4 | Q92889 | 1/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.57 |
| ▸ | HPGD | P15428 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | TYMS | P04818 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | BRD1 | O95696 | 1/20 | 0.43 |
| ▸ | TAF1 | P21675 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20735017 | 0.87 | ALDH1A1 (0.52) | ALDH1A1KDM4EMAPTTDP1HPGD | |
| SCHEMBL20735085 | 0.84 | ALDH1A1 (0.50) | ALDH1A1KDM4EMAPTTDP1HPGD | |
| SCHEMBL4860229 | 0.83 | CYP1B1 (0.66) | ALDH1A1KDM4EPOLBMAPTLMNA | |
| SCHEMBL7646060 | 0.83 | KEAP1 (0.57) | ALDH1A1KDM4ECYP1A2POLBMAPT | |
| SCHEMBL20735163 | 0.83 | ALDH1A1 (0.49) | ALDH1A1KDM4EMAPTTDP1HPGD | |
| SCHEMBL20735199 | 0.83 | ALDH1A1 (0.49) | ALDH1A1KDM4ETDP1HPGDKMT2A | |
| SCHEMBL20735248 | 0.83 | ALDH1A1 (0.49) | ALDH1A1KDM4EHPGDKMT2ACYP1B1 | |
| SCHEMBL20735196 | 0.83 | ALDH1A1 (0.49) | ALDH1A1KDM4EMAPTTDP1HPGD | |
| SCHEMBL10261468 | 0.81 | ALDH1A1 (0.57) | ALDH1A1KDM4EMAPTTDP1HPGD | |
| SCHEMBL10260482 | 0.81 | ALDH1A1 (0.57) | ALDH1A1KDM4EMAPTTDP1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070189987-A1 | Composition comprising a monomeric compound with an optical effect, process using said composition, monomeric compound, polymer comprising the same and use thereof | LUUKAS TIMO | 2007-08-16 | — | — | US | disclosed |
| US-20070189987-A1 | Composition comprising a monomeric compound with an optical effect, process using said composition, monomeric compound, polymer comprising the same and use thereof | LUUKAS TIMO | 2007-08-16 | — | — | US | disclosed |
| US-20070189987-A1 | Composition comprising a monomeric compound with an optical effect, process using said composition, monomeric compound, polymer comprising the same and use thereof | LUUKAS TIMO | 2007-08-16 | — | — | US | disclosed |
| EP-1725545-A1 | COMPOSITION COMPRISING AN OPTICALLY-ACTIVE MONOMERIC COMPOUND, METHOD IMPLEMENTING SAID COMPOSITION, MONOMERIC COMPOUND, POLYMER COMPRISING SAME, AND USE THEREOF | L'OREAL (FR) | 2006-11-29 | — | — | EP | disclosed |
| WO-2006000658-A1 | DISPERSION OF ETHYLENE POLYMER PARTICLES, COMPOSITION CONTAINING SAME AND METHOD FOR TREATMENT | L'OREAL (FR) | 2006-01-05 | — | — | WO | disclosed |
| WO-2005097776-A1 | COMPOSITION COMPRISING AN OPTICALLY-ACTIVE MONOMERIC COMPOUND, METHOD IMPLEMENTING SAID COMPOSITION, MONOMERIC COMPOUND, POLYMER COMPRISING SAME, AND USE THEREOF | L'OREAL (FR) | 2005-10-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070189987-A1 | Composition comprising a monomeric compound with an optical effect, process using said composition, monomeric compound, polymer comprising the same and use thereof | KRT18, MITF, CUTA | ALDH1A1 2078/4885KDM4E 1921/4885CYP1A2 2919/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.